Yuyu Pharmaceutical has established a subsidiary in the United States to target the U.S. pet pharmaceuticals and health supplement market directly. This is its second move in the pet business, following its investment in a U.S. startup last April.

Yuyu Pharma’s plant in Jecheon, North Chungcheong Province (Courtesy of Yuyu Pharma)
Yuyu Pharma’s plant in Jecheon, North Chungcheong Province (Courtesy of Yuyu Pharma)

Yuyu Pharmaceutical said Wednesday that it has invested $4.5 million to establish Yuyu Ventures, a U.S. holding company. Yuyu Ventures manages two subsidiaries: Yuyu Bio and Mervyn's Petcare.

Yuyu Bio is developing a pet biopharmaceutical business. It focuses on recombinant protein therapeutics with extended duration of action and improved compliance. Among chronic pet diseases, it is especially working on treatments for feline stomatitis and is advancing clinical candidate compounds.

Mervyn's Petcare operates in the pet health supplement sector, focusing on cat-specific products for joints, skin, gut health, and multivitamins. Together with Yuyu Bio, the first products—a dental health supplement and stick-type nutritional supplement for cats—are planned for a first-half 2026 launch in the U.S. market, and distribution channel preparations are underway.

Yuyu Bio and Mervyn's Petcare, subsidiaries under Yuyu Ventures, have established an office at the Magnify UCLA Campus, a startup incubation program operated by the California NanoSystems Institute (CNSI). This move significantly reduces initial costs such as office space rental. Currently, only 22 companies, including Yuyu Bio and Mervyn's Petcare, are enrolled in the Magnify UCLA Campus.

“While preparing to enter the pet industry, we discovered significant growth potential, particularly in cat-related products. Yuyu Bio and Mervyn's Petcare will focus on cat biopharmaceuticals and health functional foods,” Yuyu Pharmaceutical CEO Robert Won-sang Yu said. “We have recruited experienced partners who have directly managed pet businesses in the U.S. These partners achieved annual sales of tens of millions of dollars. We aim to accelerate our business expansion.”

According to the American Pet Products Association, the number of pet-owning households in the U.S. is projected to reach 94 million by 2025, accounting for 51 percent of all households. Among these, 49 million households are estimated to own cats.

Copyright © KBR Unauthorized reproduction, redistribution prohibited